Name
A. Drug Pricing Reform and Site Neutrality: What Oncology Leaders Need to Watch
Date & Time
Wednesday, November 4, 2026, 8:30 AM - 9:10 AM
Speakers
Robert A. Winn, MD, Cancer Center Director, Fox Chase Cancer Center
Anthony Paravati, MD, MBA, Executive Medical Director, Oncology Service Line and Chief, Radiation Oncology, Kettering Health Cancer Care
Ajaz Khan, MD, MBA, President, Medical Staff and Chief, Medical Oncology, City of Hope Cancer Center Chicago
Anthony Paravati, MD, MBA, Executive Medical Director, Oncology Service Line and Chief, Radiation Oncology, Kettering Health Cancer Care
Ajaz Khan, MD, MBA, President, Medical Staff and Chief, Medical Oncology, City of Hope Cancer Center Chicago
Description
This panel will explore how evolving drug pricing policy and site-neutral payment proposals could reshape the financial and operational landscape for cancer programs. Speakers will discuss the potential implications for reimbursement, infusion services and where oncology care is delivered across hospital and community settings. The conversation will examine how leaders will monitor regulatory developments, assess risk to their programs and plan for a range of policy outcomes. Attendees will hear perspectives on preparing oncology service lines to remain financially sustainable while maintaining patient access to care.
Location Name
Lucerne 1
Session Type
Keynote Panel
Moderated by
Elizabeth Gregerson, Assistant Editor, Becker's Healthcare
Moderator Email Address
egregerson@beckershealthcare.com